Xtx Topco LTD Scynexis Inc Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Scynexis Inc stock. As of the latest transaction made, Xtx Topco LTD holds 17,111 shares of SCYX stock, worth $17,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,111

Holding current value

$17,111

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$1.27 - $2.23 $21,730 - $38,157	17,111 New	17,111 $25,000
Q3 2023 Nov 13, 2023	BUY	$1.93 - $3.64 $39,466 - $74,434	20,449 New	20,449 $46,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

13.7M

Call Options Held

21.9K

Put Options Held

2.6K

Federated Hermes, Inc. Pittsburgh, PA

3.6M
Shares

$3.6 Million
0.01% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

2.24M
Shares

$2.24 Million
0.4% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$1.69 Million
0.0% of portfolio
Avidity Partners Management LP Dallas, TX

1.45M
Shares

$1.45 Million
0.13% of portfolio
Amh Equity LTD

600K
Shares

$600,000
1.24% of portfolio

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $32.7M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account